CN109641905A - 一种甲氨蝶呤或其盐的纯化工艺 - Google Patents
一种甲氨蝶呤或其盐的纯化工艺 Download PDFInfo
- Publication number
- CN109641905A CN109641905A CN201780042040.4A CN201780042040A CN109641905A CN 109641905 A CN109641905 A CN 109641905A CN 201780042040 A CN201780042040 A CN 201780042040A CN 109641905 A CN109641905 A CN 109641905A
- Authority
- CN
- China
- Prior art keywords
- organic solvent
- mtx
- methotrexate
- purifying process
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种工艺简单,便于操作、收率较高、质量重现性较好的甲氨蝶呤或其盐的纯化工艺。该工艺包括提供甲氨蝶呤的水性溶液、预处理及过滤、调碱和结晶四个步骤。
Description
PCT国内申请,说明书已公开。
Claims (12)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610649766.1A CN107698592A (zh) | 2016-08-09 | 2016-08-09 | 一种甲氨蝶呤盐的纯化工艺 |
CN2016106497661 | 2016-08-09 | ||
PCT/CN2017/095805 WO2018028496A1 (zh) | 2016-08-09 | 2017-08-03 | 一种甲氨蝶呤或其盐的纯化工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109641905A true CN109641905A (zh) | 2019-04-16 |
CN109641905B CN109641905B (zh) | 2021-04-27 |
Family
ID=61161643
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610649766.1A Pending CN107698592A (zh) | 2016-08-09 | 2016-08-09 | 一种甲氨蝶呤盐的纯化工艺 |
CN201780042040.4A Active CN109641905B (zh) | 2016-08-09 | 2017-08-03 | 一种甲氨蝶呤或其盐的纯化工艺 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610649766.1A Pending CN107698592A (zh) | 2016-08-09 | 2016-08-09 | 一种甲氨蝶呤盐的纯化工艺 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN107698592A (zh) |
WO (1) | WO2018028496A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109553619A (zh) * | 2017-09-26 | 2019-04-02 | 北京斯利安药业有限公司 | 一种甲氨蝶呤的制备方法 |
CN112851676A (zh) * | 2021-01-25 | 2021-05-28 | 贵州医科大学 | 一种甲氨蝶呤的合成工艺 |
CN113504315A (zh) * | 2021-05-31 | 2021-10-15 | 北京斯利安药业有限公司 | 一种2,4,5,6-四氨基嘧啶硫酸盐的检测方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3989703A (en) * | 1974-03-22 | 1976-11-02 | Institutul Oncologic | Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid |
US4080325A (en) * | 1976-11-17 | 1978-03-21 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of methotrexate |
US4374987A (en) * | 1980-08-14 | 1983-02-22 | American Cyanamid Company | Process for the preparation of high purity methotrexate and derivatives thereof |
CN102399224A (zh) * | 2011-10-21 | 2012-04-04 | 湖州展望药业有限公司 | 一种低铁甲氨蝶呤的制备方法 |
-
2016
- 2016-08-09 CN CN201610649766.1A patent/CN107698592A/zh active Pending
-
2017
- 2017-08-03 CN CN201780042040.4A patent/CN109641905B/zh active Active
- 2017-08-03 WO PCT/CN2017/095805 patent/WO2018028496A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3989703A (en) * | 1974-03-22 | 1976-11-02 | Institutul Oncologic | Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid |
US4080325A (en) * | 1976-11-17 | 1978-03-21 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Synthesis of methotrexate |
US4374987A (en) * | 1980-08-14 | 1983-02-22 | American Cyanamid Company | Process for the preparation of high purity methotrexate and derivatives thereof |
CN102399224A (zh) * | 2011-10-21 | 2012-04-04 | 湖州展望药业有限公司 | 一种低铁甲氨蝶呤的制备方法 |
Non-Patent Citations (1)
Title |
---|
周蓓等: "甲氨蝶呤纯化工艺的改进", 《中国医药工业杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109641905B (zh) | 2021-04-27 |
WO2018028496A1 (zh) | 2018-02-15 |
CN107698592A (zh) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10934257B2 (en) | Method for preparing pimavanserin and tartrate thereof by using triphosgene | |
CN109641905A (zh) | 一种甲氨蝶呤或其盐的纯化工艺 | |
TWI703163B (zh) | 舒更葡糖鈉之製備方法及其晶型 | |
CN103613557B (zh) | 一种磁共振成像对比剂钆布醇的制备方法 | |
CN104926790A (zh) | 一种高纯度 Vonoprazan Fumarate化合物及其中间体、杂质以及它们的制备方法 | |
WO2020042876A1 (zh) | 一种卡利拉嗪的合成方法 | |
CN107629001B (zh) | 一种抗癌药物乐伐替尼的合成方法 | |
CN104277053B (zh) | 一种头孢地嗪及其中间体头孢地嗪酸的制备方法 | |
CN106045995B (zh) | 一种5‑溴‑1H‑吡咯并[2,3‑b]吡啶的合成方法 | |
CN111377861A (zh) | 一种硫酸羟氯喹的纯化方法 | |
CN107935870A (zh) | 一种2‑甲氨基‑5‑氯二苯甲酮的合成方法 | |
CN106518729A (zh) | 盐酸鲁拉西酮中间体的制备方法 | |
CN113956198A (zh) | 罗沙司他的杂质、其制备方法及其应用 | |
CN107311961A (zh) | 一种多肽缩合试剂comu的合成工艺 | |
CN110590896B (zh) | 雌酚酮硫酸酯哌嗪的制备方法 | |
CN112694445A (zh) | 一种噁拉戈利钠中间体的纯化方法 | |
CN105985296B (zh) | 一种可以工业化的lesinurad中间体1-萘基三唑硫酮的精制工艺 | |
EP0111569B1 (en) | Hydroxyalkanesulfonic acids and their derivatives, and process for their preparation | |
KR100455241B1 (ko) | 이중원추형결정형태를갖는2-아미노-6-클로로퓨린및그의제조방법 | |
JPH10310568A (ja) | N−アルコキシカルボニル−l−アスパラギン | |
CN106397518B (zh) | 一种氯法拉滨的合成方法 | |
CN109535025B (zh) | 一种艾伏尼布中间体3,3-二氟环丁胺盐酸盐的制备方法 | |
CN114401957A (zh) | 一种喹唑啉衍生物的制备方法及其结晶 | |
JP2942380B2 (ja) | メタクリルアミドの精製方法 | |
CN117088939A (zh) | 一种匹多莫德的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |